Page last updated: 2024-10-28

ibudilast and Astrocytoma, Grade IV

ibudilast has been researched along with Astrocytoma, Grade IV in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Alban, TJ1
Bayik, D1
Otvos, B1
Rabljenovic, A1
Leng, L1
Jia-Shiun, L1
Roversi, G1
Lauko, A1
Momin, AA1
Mohammadi, AM1
Peereboom, DM1
Ahluwalia, MS1
Matsuda, K2
Yun, K1
Bucala, R1
Vogelbaum, MA1
Lathia, JD1
Ha, W1
Sevim-Nalkiran, H1
Zaman, AM1
Khasraw, M1
Nowak, AK1
Chung, L1
Baxter, RC1
McDonald, KL1

Other Studies

2 other studies available for ibudilast and Astrocytoma, Grade IV

ArticleYear
Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Animals; Brain Neoplasms; Glioblastoma; Humans; Immunotherapy; Macrophage Migration-Inhibitory Facto

2020
Ibudilast sensitizes glioblastoma to temozolomide by targeting Macrophage Migration Inhibitory Factor (MIF).
    Scientific reports, 2019, 02-27, Volume: 9, Issue:1

    Topics: Aged; Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; DNA Methylation; DNA Modifi

2019